Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hietarinta

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Annals of Medicine|August 1, 1996
Clinical significance of antinuclear antibodies in systemic rheumatic diseasesM Hietarinta, O Lassila
Scandinavian Journal of Rheumatology|January 1, 1994
Association of anti-U1RNP- and anti-Scl-70-antibodies with neurological manifestations in systemic sclerosis (scleroderma)M Hietarinta, O Lassila, A Hietaharju
British Journal of Rheumatology|April 1, 1994
Association of HLA antigens with anti-Scl-70-antibodies and clinical manifestations of systemic sclerosis (scleroderma)M Hietarinta, J Ilonen, O Lassila, et al.
Muscle & Nerve|November 1, 1993
Peripheral neuromuscular manifestations in systemic sclerosis (scleroderma)A Hietaharju, S Jääskeläinen, H Kalimo, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|February 24, 2001
Erythema migrans--influence of posture. Case reportJ Oksi, M Hietarinta, M K Viljanen
International Urogynecology Journal and Pelvic Floor Dysfunction|May 11, 2000
Lower urinary tract symptoms in patients with Sjögren's syndrome and systemic lupus erythematosusM Haarala, A Alanen, M Hietarinta, et al.
Acta Neurologica Scandinavica|May 1, 1993
Central nervous system involvement and psychiatric manifestations in systemic sclerosis (scleroderma): clinical and neurophysiological evaluationA Hietaharju, S Jääskeläinen, M Hietarinta, et al.
British Journal of Rheumatology|April 1, 1993
Familial scleroderma: HLA antigens and autoantibodiesM Hietarinta, S Koskimies, O Lassila, et al.
Scandinavian Journal of Rheumatology|January 1, 1984
Xanthoma tendinosum in a normolipemic ectodermal dysplasia patientS Jalava, M Hietarinta, S Einola, et al.
The Journal of Investigative Dermatology|April 16, 1998
Activation of tissue inhibitor of metalloproteinases-3 (TIMP-3) mRNA expression in scleroderma skin fibroblastsL Mattila, K Airola, M Ahonen, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Annals of Medicine|August 1, 1996
Clinical significance of antinuclear antibodies in systemic rheumatic diseasesM Hietarinta, O Lassila
Scandinavian Journal of Rheumatology|January 1, 1994
Association of anti-U1RNP- and anti-Scl-70-antibodies with neurological manifestations in systemic sclerosis (scleroderma)M Hietarinta, O Lassila, A Hietaharju
British Journal of Rheumatology|April 1, 1994
Association of HLA antigens with anti-Scl-70-antibodies and clinical manifestations of systemic sclerosis (scleroderma)M Hietarinta, J Ilonen, O Lassila, et al.
Muscle & Nerve|November 1, 1993
Peripheral neuromuscular manifestations in systemic sclerosis (scleroderma)A Hietaharju, S Jääskeläinen, H Kalimo, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|February 24, 2001
Erythema migrans--influence of posture. Case reportJ Oksi, M Hietarinta, M K Viljanen
International Urogynecology Journal and Pelvic Floor Dysfunction|May 11, 2000
Lower urinary tract symptoms in patients with Sjögren's syndrome and systemic lupus erythematosusM Haarala, A Alanen, M Hietarinta, et al.
Acta Neurologica Scandinavica|May 1, 1993
Central nervous system involvement and psychiatric manifestations in systemic sclerosis (scleroderma): clinical and neurophysiological evaluationA Hietaharju, S Jääskeläinen, M Hietarinta, et al.
British Journal of Rheumatology|April 1, 1993
Familial scleroderma: HLA antigens and autoantibodiesM Hietarinta, S Koskimies, O Lassila, et al.
Scandinavian Journal of Rheumatology|January 1, 1984
Xanthoma tendinosum in a normolipemic ectodermal dysplasia patientS Jalava, M Hietarinta, S Einola, et al.
The Journal of Investigative Dermatology|April 16, 1998
Activation of tissue inhibitor of metalloproteinases-3 (TIMP-3) mRNA expression in scleroderma skin fibroblastsL Mattila, K Airola, M Ahonen, et al.
Pageof 2